Hua Linda Cai

Dr. Hua Linda Cai

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
KHKai Huang
Kai Huang
PZPan Zhang
Pan Zhang
ZZZhenghao Zhang
Zhenghao Zhang
JYJi Youn Youn
Ji Youn Youn
CWChen Wang
Chen Wang
HCHua Linda Cai
Hua Linda Cai

7 October 2019 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
YZYixuan Zhang
Yixuan Zhang
PMPriya Murugesan
Priya Murugesan
KHKai Huang
Kai Huang
HCHua Linda Cai
Hua Linda Cai

1 April 2020 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
HCHua Linda Cai
Hua Linda Cai

1 September 2020 in Redox Biology
Verified
Journal Article
Open access
JJJinyao Jiang
Jinyao Jiang
KHKai Huang
Kai Huang
SXShiqing Xu
Shiqing Xu
JGJoe G.N. Garcia
Joe G.N. Garcia
CWChen Wang
Chen Wang
HCHua Linda Cai
Hua Linda Cai
Increased pulmonary vascular permeability due to endothelial cell (EC) barrier dysfunction is a major pathological feature of acute respiratory distress syndrome/acute lung injury (ARDS/ALI), which is a devastating critical illness with high incidence and excessive mortality. Activation of NADPH oxidase (NOX) induces EC dysfunction via production of reactive oxygen species (ROS). However, the role(s) of NOX isoform(s), and their downstream signaling events, in the development of ARDS/ALI have remained unclear. Cecal Ligation Puncture (CLP) was used to induce preclinical septic ALI in wild-type mice and mice deficient in NOX2 or p47phox, or mice transfected of control siRNA, NOX1 or NOX4 siRNA in vivo. The survival rate of the CLP group at 24 h (26.6%, control siRNA treated) was substantially improved by NOX4 knockdown (52.9%). Mice lacking NOX2 or p47phox, however, had worse outcomes after CLP (survival rates at 0% and 8.3% respectively), whereas NOX1-silenced mice had similar survival rate (30%). NOX4 knockdown attenuated lung ROS production in septic mice, whereas NOX1 knockdown, NOX2 knockout, or p47phox knockout in mice had no effects. In addition, NOX4 knockdown attenuated redox-sensitive activation of the CaMKII/ERK1/2/MLCK pathway, and restored expression of EC tight junction proteins ZO-1 and Occludin to maintain EC barrier integrity. Correspondingly, NOX4 knockdown in cultured human lung microvascular ECs also reduced LPS-induced ROS production, CaMKII/ERK1/2/MLCK activation and EC barrier dysfunction. Scavenging superoxide in vitro and in vivo with TEMPO, or inhibiting CaMKII activation with KN93, had similar effects as NOX4 knockdown in preserving EC barrier dysfunction. In summary, we have identified a novel, selective and causal role of NOX4 (versus other NOX isoforms) in inducing lung EC barrier dysfunction and injury/mortality in a preclinical CLP-induced septic model, which involves redox-sensitive activation of CaMKII/ERK1/2/MLCK pathway. Targeting NOX4 may therefore prove to an innovative therapeutic option that is markedly effective in treating ALI/ARDS.

1 June 2015 in Journal Of Hypertension
Verified
Journal Article
Closed access
QLQiang Li
Qiang Li
JYJi-Youn Youn
Ji-Youn Youn
HCHua Linda Cai
Hua Linda Cai
Reduced nitric oxide bioavailability contributes to endothelial dysfunction and hypertension. The endothelial isoform of nitric oxide synthase (eNOS) is responsible for the production of nitric oxide within the endothelium. Loss of eNOS cofactor tetrahydrobiopterin to initial increase in oxidative stress leads to uncoupling of eNOS, in which the enzyme produces superoxide anion rather than nitric oxide, further substantiating oxidative stress to induce vascular pathogenesis. The current review focuses on recent advances on the molecular mechanisms and consequences of eNOS dysfunction in hypertension, and potential novel therapeutic strategies restoring eNOS function to treat hypertension.

1 September 2013 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
JYJi-Youn Youn
Ji-Youn Youn
JZJun Zhang
Jun Zhang
YZYixuan Zhang
Yixuan Zhang
HCHouzao Chen
Houzao Chen
DLDepei Liu
Depei Liu
HCHua Linda Cai
Hua Linda Cai